Our IP specialists work at all stage of the IP life cycle and provide strategic advice about patent, trade mark and registered designs, as well as any IP-related disputes and legal and commercial requirements.
Robert handles patent work in our chemistry team. Dealing mainly with drafting and prosecuting and advising on global portfolio management and invention capture, he has particular experience in the pharmaceutical and industrial chemistry sectors. He is also a leading member of our designs team.
Areas of Expertise
- Antibody-drug conjugates
- Small-molecule pharmaceuticals
- Polymorphic forms of drugs
Robert works with a range of clients including British universities, charities, spin out companies, SMEs and multi-nationals.
Robert has a first class degree in chemistry from Oxford University which included study and research in quantum chemistry. He joined Mewburn Ellis in 1995, qualifying as a Chartered Patent Attorney and a European Patent Attorney in 1999 and is also a Representative authorised to act before the EUIPO. He joined the partnership in 2001.
Formerly President of FICPI-UK (2011-2015), Robert is currently Vice-President of FICPI’s Work and Study Commission (CET) in which capacities he meets the European Commission, EPO, EUIPO, WIPO and other patent offices. He is also a member of the Designs and Copyright committee of CIPA and regularly speaks at conferences on a variety of topics including design law, entitlement to priority and privilege.
Robert is recognised in IAM Patent 1000, Managing IP, Who’s Who Legal and The Legal 500.
He is described as “a chemistry and materials maven, the depth of whose analysis never fails to amaze” , his “first-rate global portfolio management work has won him admirers on all continents.” What makes him stand-out is “his technical expertise, the quality of his advice, and successful representation in European opposition proceedings.”
Robert “balances his penchant for pharmaceutical patents with a thriving designs practice” - IAM Patent 1000, 2020
'Key Lawyer' - The Legal 500, 2019